- Home
- ALLY vs ASND Comparison
ALLY vs ASND Comparison
Compare ALLY & ASND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALLY
- ASND
- Stock Information
- Founded
- ALLY 1919
- ASND 2006
- Country
- ALLY United States
- ASND Denmark
- Employees
- ALLY N/A
- ASND N/A
- Industry
- ALLY Major Banks
- ASND Biotechnology: Pharmaceutical Preparations
- Sector
- ALLY Finance
- ASND Health Care
- Exchange
- ALLY Nasdaq
- ASND Nasdaq
- Market Cap
- ALLY 11.3B
- ASND 9.8B
- IPO Year
- ALLY 2014
- ASND 2015
- Fundamental
- Price
- ALLY $36.95
- ASND $176.90
- Analyst Decision
- ALLY Buy
- ASND Strong Buy
- Analyst Count
- ALLY 19
- ASND 16
- Target Price
- ALLY $43.19
- ASND $218.19
- AVG Volume (30 Days)
- ALLY 4.6M
- ASND 411.5K
- Earning Date
- ALLY 07-18-2025
- ASND 05-01-2025
- Dividend Yield
- ALLY 3.24%
- ASND N/A
- EPS Growth
- ALLY N/A
- ASND N/A
- EPS
- ALLY 0.61
- ASND N/A
- Revenue
- ALLY $6,658,000,000.00
- ASND $398,509,511.00
- Revenue This Year
- ALLY $20.15
- ASND $75.05
- Revenue Next Year
- ALLY $14.71
- ASND $78.14
- P/E Ratio
- ALLY $60.50
- ASND N/A
- Revenue Growth
- ALLY N/A
- ASND 12.06
- 52 Week Low
- ALLY $29.52
- ASND $111.09
- 52 Week High
- ALLY $45.46
- ASND $183.00
- Technical
- Relative Strength Index (RSI)
- ALLY 59.20
- ASND 60.02
- Support Level
- ALLY $35.94
- ASND $169.65
- Resistance Level
- ALLY $38.05
- ASND $178.62
- Average True Range (ATR)
- ALLY 0.76
- ASND 6.77
- MACD
- ALLY 0.03
- ASND 0.03
- Stochastic Oscillator
- ALLY 70.53
- ASND 82.61
About ALLY Ally Financial Inc.
Formerly the captive financial arm of General Motors, Ally Financial became an independent publicly traded firm in 2014 and is one of the largest consumer auto lenders in the country. While the firm has expanded its product offerings over time, it remains primarily focused on auto lending, with more than 70% of its loan book in consumer auto loans and dealer financing. Ally also offers auto insurance, commercial loans, credit cards, and holds a portfolio of mortgage debt, giving the bank a diversified business model, which includes brokerage services.
About ASND Ascendis Pharma A/S
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology which includes TransCon PTH, TransCon CNP, and others. It operates in North America, Europe, and Rest of the world and derives the majority of its revenue from North America.